These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15179681)

  • 1. [Insulin resistance in epileptic patients during treatment of valproic acid].
    Ding MP; Bao YY; Chen Z; Liu ZR; Xu LL
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 May; 33(3):216-8. PubMed ID: 15179681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy.
    Luef G; Abraham I; Hoppichler F; Trinka E; Unterberger I; Bauer G; Lechleitner M
    Metabolism; 2002 Oct; 51(10):1274-8. PubMed ID: 12370846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
    Hamed SA; Fida NM; Hamed EA
    Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study.
    Sidhu HS; Srinivas R; Sadhotra A
    Seizure; 2017 May; 48():15-21. PubMed ID: 28365440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting insulin and HOMA-index changes in patients treated with valproic acid.
    Mania M; Javashvili L; Kasradze S; Okujava N
    Georgian Med News; 2011 Oct; (199):48-52. PubMed ID: 22155806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
    Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
    Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting serum insulin and lipid levels in men with epilepsy.
    Pylvänen V; Knip M; Pakarinen AJ; Turkka J; Kotila M; Rättyä J; Myllylä VV; Isojärvi JI
    Neurology; 2003 Feb; 60(4):571-4. PubMed ID: 12601094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy.
    Kanemura H; Sano F; Maeda Y; Sugita K; Aihara M
    Seizure; 2012 Sep; 21(7):496-500. PubMed ID: 22694920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid.
    Nisha Y; Bobby Z; Wadwekar V
    Seizure; 2018 Aug; 60():57-60. PubMed ID: 29906708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V; Pakarinen A; Knip M; Isojärvi J
    Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Investigation of Insulin Resistance in Two Groups of Epileptic Patients Treated with Sodium Valproate and Carbamazepine.
    Najafi MR; Bazooyar B; Zare M; Aghaghazvini MR; Ansari B; Rajaei A; Dashti M
    Adv Biomed Res; 2017; 6():25. PubMed ID: 28401072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum insulin and leptin levels in valproate-associated obesity.
    Pylvänen V; Knip M; Pakarinen A; Kotila M; Turkka J; Isojärvi JI
    Epilepsia; 2002 May; 43(5):514-7. PubMed ID: 12027912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ghrelin in weight gain and growth in epileptic children using valproate.
    Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S
    J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain.
    Noai M; Soraoka H; Kajiwara A; Tanamachi Y; Oniki K; Nakagawa K; Ishitsu T; Saruwatari J
    Acta Neurol Scand; 2016 Mar; 133(3):216-23. PubMed ID: 26223287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance in epileptic girls who gain weight after therapy with valproic acid.
    Verrotti A; Basciani F; De Simone M; Trotta D; Morgese G; Chiarelli F
    J Child Neurol; 2002 Apr; 17(4):265-8. PubMed ID: 12088081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
    Minkova GD; Getova DP
    Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight gain in epileptic patients during treatment with valproic acid: a retrospective study.
    Corman CL; Leung NM; Guberman AH
    Can J Neurol Sci; 1997 Aug; 24(3):240-4. PubMed ID: 9276111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and endocrine effects of valproic acid chronic treatment.
    Belcastro V; D'Egidio C; Striano P; Verrotti A
    Epilepsy Res; 2013 Nov; 107(1-2):1-8. PubMed ID: 24076030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
    Sidhu HS; Srinivasa R; Sadhotra A
    Epilepsy Res; 2018 Jan; 139():20-27. PubMed ID: 29144993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.